Effects of SIBO and rifaximin therapy on MHE caused by hepatic cirrhosis.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Clinical and Experimental Medicine

• Publication date

  2015-02-15

• Fields of study

  Medicine

• Identifiers
  PMID 25932262PMCID PMC4402909
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microbial Translocation in Chronic Liver Diseases

  2012cited by this paper
• Rifaximin in the treatment of hepatic encephalopathy

  2011cited by this paper
• Rifaximin treatment for reduction of risk of overt hepatic encephalopathy recurrence

  2011cited by this paper
• Changing face of hepatic encephalopathy: role of inflammation and oxidative stress.

  2010cited by this paper
• Rifaximin treatment in hepatic encephalopathy.

  2010cited by this paper
• Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy.

  2010cited by this paper
• Small‐intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease

  2009cited by this paper
• Review of rifaximin as treatment for SIBO and IBS.

  2009cited by this paper
• Role of ammonia and inflammation in minimal hepatic encephalopathy

  2007cited by this paper
• Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections

  2005cited by this paper
• Treatment of hepatic encephalopathy.

  2005cited by this paper
• Rifaximin, a Poorly Absorbed Antibiotic: Pharmacology and Clinical Potential

  2005cited by this paper
• Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis

  2004cited by this paper
• Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials

  2004cited by this paper
• Neuropsychological characterization of hepatic encephalopathy.

  2001cited by this paper
• Treatment of hepatic encephalopathy.

  2001cited by this paper
• Subclinical hepatic encephalopathy impairs daily functioning

  1998cited by this paper

• [SIBO, from myth to reality].

  2024cites this paper
• Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study

  2024cites this paper
• Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023?

  2023cites this paper
• Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota

  2023cites this paper
• Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients

  2023cites this paper
• Small Intestinal Bacterial Overgrowth Is Associated with Poor Prognosis in Cirrhosis

  2023cites this paper
• Minimal Hepatic Encephalopathy Affects Daily Life of Cirrhotic Patients: A Viewpoint on Clinical Consequences and Therapeutic Opportunities

  2022cites this paper
• Усунення надлишкового бактеріального росту в тонкій кишці як допоміжний метод лікування цукрового діабету 2 типу

  2022cites this paper
• Hepatic Encephalopathy in Cirrhotic Patients and Risk of Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-Analysis

  2022cites this paper
• Rifaximin: unique selective antibiotic for the treatment of gastrointestinal diseases

  2021cites this paper
• Review of Rifaximin: A Summary of the Current Evidence and Benefits Beyond Licensed Use

  2021cites this paper
• Efficacy of rifaximin in treating with small intestine bacterial overgrowth: a systematic review and meta-analysis

  2021cites this paper
• Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis

  2021cites this paper
• Small Intestinal Bacterial Overgrowth Diagnosed by a Breath Test and Improved by Rifaximin in a Patient with Hepatic Encephalopathy and Alcoholic Liver Cirrhosis

  2020cites this paper
• ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth.

  2020cites this paper
• Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients

  2020cites this paper
• Gut Microbiota and Liver Injury (II): Chronic Liver Injury.

  2020cites this paper
• The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders

  2020cites this paper
• Minimal Hepatic Encephalopathy: Effect of H. pylori infection and small intestinal bacterial overgrowth treatment on clinical outcomes

  2020cites this paper
• Small Intestinal Bacterial Overgrowth: How to Diagnose and Treat (and Then Treat Again).

  2020cites this paper
• Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis.

  2019cites this paper
• Is small intestinal bacterial overgrowth a cause of hyperdynamic circulation in cirrhosis?

  2019influential citation
• Retrospective Study 5288 Safety of hepatitis B virus core antigen-positive grafts in liver transplantation: A single-center experience in China

  2019cites this paper
• Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy.

  2018cites this paper
• 3-Nitro-Tyrosine as a Biomarker of Minimal Hepatic Encephalopathy in Patients with Liver Cirrhosis

  2018cites this paper
• Quality of life in patients with minimal hepatic encephalopathy

  2018cites this paper
• The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies

  2018cites this paper
• Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis

  2018cites this paper
• Wodorowe testy oddechowe – metodyka, znaczenie w diagnostyce gastroenterologicznej

  2017cites this paper
• Use of rifaximin in gastrointestinal and liver diseases.

  2016cites this paper
• Papel de la rifaximina en el tratamiento de la encefalopatía hepática

  2016cites this paper
• Role of rifaximin in the treatment of hepatic encephalopathy

  2016cites this paper
• Papel de la rifaximina en el tratamiento de la encefalopatía hepática

  2016cites this paper
• [Role of rifaximin in the treatment of hepatic encephalopathy].

  2016cites this paper
• Recent developments in the diagnosis and treatment of covert/minimal hepatic encephalopathy

  2016cites this paper
• Small Intestinal Bacterial Overgrowth is not Associated with Minimal Hepatic Encephalopathy in Patients with Liver Cirrhosis

  2016cites this paper
• Reversibility of minimal hepatic encephalopathy following liver transplantation in Egyptian cirrhotic patients

  2016cites this paper
• Diagnosis and treatment of small intestinal bacterial overgrowth

  2016cites this paper
• World Journal of Gastroenterology

  year unknowncites this paper